MyoKardia - Ownership and Business Overview

Life ScienceCompany

MyoKardia Ownership

Who owns MyoKardia?

MyoKardia is owned by Bristol-Myers Squibb. It was acquired on October 5, 2020.

MyoKardia Business Overview

Where is MyoKardia headquartered?

MyoKardia is headquartered in South San Francisco, California.

What is MyoKardia’s revenue?

MyoKardia disclosed revenue of 34M USD for 2018 and 23M USD for 2017.

How many employees does MyoKardia have?

MyoKardia has 275 employees.

What sector is MyoKardia in?

MyoKardia is a life science company.

When was MyoKardia founded?

MyoKardia was founded in 2012.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.

MyoKardia, Inc.

333 Allerton Avenue,
South San Francisco, California 94080
United States,
(650) 741-0900
www.myokardia.com

MyoKardia, Inc. is a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases. MyoKardia was founded in 2012 and is based in South San Francisco, California.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.